Top

Deployable Medical Oxygen Generation System (DMOGS)

Active

SPM2D1-09-R-0025Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

The Defense Supply Center of Philadelphia, representing the Army and Air Force, is seeking proposals for a commercial, deployable medical oxygen generation system (DMOGS) to replace the current 120 liter per minute capacity units used in field hospitals. The system is required to produce high purity (93% USP) oxygen at a minimum of 120 LPM with an objective of 200 LPM and be capable of filling various cylinder sizes up to specific pressure thresholds. It must operate reliably in extreme environments ranging from desert heat to sub-zero temperatures, provide continuous 24/7 operation, and prioritize patient oxygen supply while simultaneously filling cylinders. The system should be compatible with fluctuating alternating current power sources, meet specific weight and dimension requirements for transportability, including fitting multiple units onto standard military pallets for airlift via C-130 aircraft, and be rugged enough to withstand harsh handling conditions. Additionally, the system must be FDA approved and designed to be forklift portable or skid-compatible. This procurement will be a firm fixed-price indefinite delivery/indefinite quantity contract, potentially spanning five years with one base year and four one-year options, and an estimated maximum contract value of $50 million. Multiple awards are anticipated, and the solicitation will be issued unrestricted with a guaranteed minimum order value. Prospective contractors must submit pre-award samples for operational and environmental testing, provide training materials, and submit FDA certification documentation prior to award. The acquisition will be conducted under FAR Part 12 as a modified commercial item, and the solicitation will be available on the DLA Internet Bid Board System with a 30-day proposal submission period. The contracting office is located in Philadelphia, PA, with designated points of contact for acquisition-related inquiries.

General Info

Army and Air Force seek rugged, FDA-approved deployable oxygen systems with 120-200 LPM capacity.

Agency

N/A

NAICS

423450 - Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

Place of Performance

Defense Logistics Agency Defense Supply Center of Philadelphia - Medical 700 Robbins Avenue, PHILADELPHIA, PA, 19111-5096, USA

Set-Aside

NONE

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

1 update

PhasePresolicitation

PostedJul 16

Presolicitation

Notice updatedJan 7

Notice details unchanged. Attachments may have changed.

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyN/A

Contacts2 people available

OfficeN/A

Organization / Agency

N/A

Office AddressN/A

Contacts

Beatrice Lopez-PollardAcquisition Specialist

contact@example.gov

+1 (555) 000-0000

Donna F. RadayContracting Officer

contact@example.gov

+1 (555) 000-0000

Full Description

There are two (2) revisions to the Key Performance Parameters (KPPs) in the original synopsis. This amendment is note a revision to number 7 and 8 of the KPPs. On behalf of the Army and Air Force, the Defense Supply Center of Philadelphia (DSCP) is looking for a replacement system for the currently fielded 120 liter per minute (lpm) oxygen generation systems. The system provides 93% USP oxygen to field hospitals and also has cylinder fill capability. The desired replacement system would be able to stand up to the environmental extremes encountered in a desert and sub-zero temperature environments. Item: A commercial, point of use, medical oxygen generating unit that will be used at forward deployed medical treatment facilities to supply medical grade oxygen directly to patients, fill cylinders, or be used as an oxygen and compressed air source in conjunction with ventilators and anesthesia equipment. Key Performance Parameters (KPPs): Note: (O) = Objective; (T) = Threshold 1. Shall produce > 120 LPM (T), 200 LPM (O) of oxygen, USP 93% 2. Operating pressure shall be able to be regulated between 50 pounds per square inch (psi) and 60 psi (T), 100 psi (O). 3. System shall be able to fill - D, - E, - M, and - H size oxygen cylinders (correct adapters must be provided) to 2100 psi (T), 2250 psi (O). 4. Shall operate on alternating current power 110-220 - 10% VAC, 60 - 2 Hz (T), 50/60 - 2 Hz (O), single-phase OR 208-220 - 10% VAC, 60 - 2 Hz (T), 50/60 - 2 Hz (O), three-phase power without sensitivity to fluctuating power sources. 5. System shall be able to simultaneously fill cylinders and provide patient oxygen. Priority shall be given to providing the patient oxygen. 6. System shall operate continuously, 24-hours per day, 7 days a week 7. After start-up, the maximum power draw shall be 12 kW (T), 8 kW (O). 8. Full system shall not exceed a maximum weight of 2,300 lbs (T), 1,360 lbs (O). 9. The system shall be either able to be directly picked up by a forklift, or designed to be lifted and set on a skid to be transported by a forklift. 10. The system dimensions shall allow for two units (T), three units (O), to fit on a standard 463L pallet (useable area 104'L x 84'H x 96'W) to be loaded in to a C-130. 11. Shall be provided with or integrated into a case to withstand rough handling and transportation across rugged terrain. 12. The system shall be FDA approved. DSCP Hospital Supply Division intends to enter into a firm fixed-price indefinite quantity contract for the deployable medical oxygen generation system (DMOGS). This acquisition will be issued on an unrestricted basis. The performance period of the resulting contract will potentially be five (5) years, a one (1) year base period and four (4) one-year options. Multiple awards are anticipated. The aggregate annual estimated dollar value is $16 million for the base and $1 million for the each option year. The aggregate maximum is $50 million. Issuance of individual delivery orders will be by the customer(s). The Guaranteed Minimum per contract for the base year will be $6,000 and $1,000 for each option year, if exercised. This system is a modified commercial item and the requirement will be solicited under FAR Part 12. Number Note 12 (Trade Agreement Act) applies to this solicitation (DFARS 252.225-7021). The Request for Proposal (RFP) when issued will require: Prospective suppliers and manufacturers shall submit Pre-Award samples for evaluation and testing. Submissions under the Request for Proposal (RFP) may be subjected to operational and environmental testing to verify certain criteria. Vendors shall provide operator's instruction and maintenance service manuals for review. Operator/maintainer training to users/testers shall be succinct and be provided prior to testing. Contractor shall provide a complete list of all accessories that will come with the system. FDA certification can take time and the contractor shall submit paperwork to the FDA prior to testing, and the system shall be certified prior award. Copies of the solicitation will be available no sooner than July 31, 2009. To obtain a copy of the solicitation, please visit The DLA Internet Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil/ . Once the solicitation is available on DIBBS, it will remain open for 30 days. All responsible sources that submit a proposal will be considered by the Agency.